CORRECTING AND REPLACING -- Notice to All Investors of Medical Capital Holdings From the Securities Law Firm of Klayman & Toskes
NEW YORK, Aug 21, 2009 (GlobeNewswire via COMTEX) -- By Staff
Companies: Capital Holdings, Inc. (CLHD), National Securities Inc (NXSC)
In a release issued earlier today by Klayman & Toskes, P.A. under the same headline, note the removal of GunnAllen Financial, Inc., Capwest Securities, J.P. Turner & Co., and NEXT Financial from the list of brokers selling Medical Capital securities in the first paragraph. The corrected release follows:
The Securities Law Firm of Klayman & Toskes, P.A. ("K&T") (http://www.nasd-law.com) announced today that it is investigating the sales practices and due diligence of Financial Industry Regulatory Authority ("FINRA") broker-dealers who solicited customers to purchase Medical Capital Holdings' private securities in the form of notes. On July 16, 2009, the Securities and Exchange Commission ("SEC") filed fraud charges against Medical Capital Holdings in connection with the sale of $77 million of private securities. On the same day, FINRA issued a sweep notice to obtain information from several broker-dealers regarding the sale of Medical Capital securities. Various independent broker dealers sold Medical Capital securities including American Portfolios Financial Services, Inc., National Securities Corp., Securities America, Inc. and Signature Financial Group.
Retail and institutional investors who purchased Medical Capital securities from a full-service broker-dealer and sustained significant losses can contact K&T to explore their legal rights and options. The attorneys at K&T are dedicated to pursuing claims on behalf of investors who have suffered investment losses. K&T, an experienced, qualified and nationally recognized securities litigation law firm, practices exclusively in the field of securities arbitration and litigation. It continues its representation of investors throughout the world in securities arbitration and litigation matters against major Wall Street brokerage firms.
If you have information relating to this investigation or have investment losses of $200,000 or more in Medical Capital securities, please contact Steven D. Toskes, Esquire or Jahan K. Manasseh, Esquire of Klayman & Toskes, P.A., at 888-997-9956 or visit us on the web at http://www.nasd-law.com.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Klayman & Toskes P.A.
CONTACT: Klayman & Toskes, P.A. 888-997-9956
Copyright (C) 2009 GlobeNewswire. All rights reserved
News Provided by COMTEX
Companies: Capital Holdings, Inc. (CLHD), National Securities Inc (NXSC)
Related terms: broker, dealer, financial services, investigation, investment, law, legal, medical, note, retail, sec, securities
